Mechanisms of elF4E mediated transformation
eF4E介导的转化机制
基本信息
- 批准号:6678362
- 负责人:
- 金额:$ 33.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2004-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein SDS polyacrylamide gel electrophoresis cell differentiation cell growth regulation cell line cell transformation confocal scanning microscopy flow cytometry hematopoiesis immunofluorescence technique intracellular transport messenger RNA microarray technology protein protein interaction protein structure function ribosomal proteins tissue /cell culture translation factor western blottings
项目摘要
DESCRIPTION (provided by applicant): The eukaryotic initiation factor eIF4E is a key regulator of cellular growth elF4E is overexpressed in several cancers. Its overexpression results in oncogenic transformation of a variety of cell lines. This protein functions in the rate limiting step of translation initiation where it binds the 7 methyl guanosine cap moiety (m7G cap) found on all mRNAs thereby allowing the given mRNA to be translated. The effects of eIF4E on translation are not uniform, where eIF4E overexpression upregulates translation of specific transcripts more so than others. Transcripts with complex untranslated regions (UTRs) in particular are more sensitive to eIF4E levels. In general housekeeping genes do not have complex UTRs, however, several growth control proteins, such as the cyclins, do. Traditionally, elF4E transforms cells by inappropriate translation of transcripts that promote growth. However, exciting new findings indicate that a substantial fraction (up to 68%) of eIF4E forms nuclear bodies and that this fraction promotes the transport of specific transcripts, such as cyclin D1, from the nucleus to the cytoplasm without affecting transport of housekeeping genes such as GAPDH and actin. Again, the specificity appears to be mediated by the UTR structure. Our studies indicate that mutations, which disrupt the ability of eIF4E to act in translation do not disrupt its ability to transform cells. These findings represent a major paradigm shift in that eIF4E can transform cells independently of its translation functions. We hypothesize that eIF4E promotes transformation at least in part through its ability to promote the transport of growth specific mRNAs, eIF4E nuclear bodies co-localize with those containing the promyelocytic leukemia protein PML. PML is a potent negative regulator of the transport and transformation activity of eIF4E. The RING domain of PML binds directly to eIF4E, alters its conformation, reduces m7G cap mRNA affinity and suppresses transport and transformation. In addition, the myeloid specific proline rich homeodomain protein PRH, which functions in hematopoiesis binds directly to eIF4E, reduces its affinity for the m7G cap and decreases cyclin D1 mRNA transport. PRH uses a conserved eIF4E, binding site to directly bind eIF4E. Data base analysis indicates that about 200 homeodomain proteins have this site. Thus, we hypothesize that eIF4E, through interactions with these proteins plays a key rote in differentiation. We propose to 1. Determine the role of nuclear functions of eIF4E in terms of its transformation potential, 2. Determine whether eIF4E plays a role in hematopoiesis through its interactions with PRH and 3. Determine whether other homeodomains modulate eIF4E function. We believe that elucidation of the regulatory network in which elF4E functions will yield broad insights into normal growth control and differentiation.
描述(由申请人提供):真核起始因子eIF4E是细胞生长的关键调节因子,eIF4E在几种癌症中过表达。其过表达导致多种细胞系的致癌转化。该蛋白质在翻译起始的限速步骤中起作用,其中它结合在所有mRNA上发现的7甲基鸟苷帽部分(m7G帽),从而允许给定的mRNA被翻译。eIF4E对翻译的影响是不一致的,其中eIF4E过表达上调特定转录物的翻译比其他转录物更高。特别是具有复杂非翻译区(UTR)的转录本对eIF4E水平更敏感。一般来说,管家基因没有复杂的UTR,然而,一些生长控制蛋白,如细胞周期蛋白,有。传统上,eIF 4 E通过促进生长的转录本的不适当翻译来转化细胞。然而,令人兴奋的新发现表明,相当大一部分(高达68%)的eIF4E形成核小体,这部分促进特定转录本,如细胞周期蛋白D1,从细胞核到细胞质的运输,而不影响管家基因,如GAPDH和肌动蛋白的运输。同样,特异性似乎是由UTR结构介导的。我们的研究表明,破坏eIF4E翻译能力的突变不会破坏其转化细胞的能力。这些发现代表了一个重大的范式转变,即eIF4E可以独立于其翻译功能转化细胞。我们推测eIF4E促进转化至少部分是通过其促进生长特异性mRNA转运的能力,eIF4E核体与含有早幼粒细胞白血病蛋白PML的核体共定位。PML是eIF4E转运和转化活性的有效负调节剂。PML的RING结构域直接与eIF4E结合,改变其构象,降低m7G帽mRNA亲和力并抑制转运和转化。此外,在造血中起作用的骨髓特异性富含脯氨酸的同源结构域蛋白PRH直接与eIF4E结合,降低其对m7G帽的亲和力并降低细胞周期蛋白D1 mRNA的转运。PRH使用保守的eIF4E结合位点直接结合eIF4E。数据库分析表明,大约有200个同源结构域蛋白具有该位点。因此,我们假设eIF4E通过与这些蛋白质的相互作用在分化中起关键作用。我们建议1。确定eIF 4E核功能在其转化潜力方面的作用,2。确定eIF4E是否通过与PRH和3的相互作用在造血中发挥作用。确定其他同源结构域是否调节eIF4E功能。我们相信,阐明eIF4E功能的调控网络将产生对正常生长控制和分化的广泛见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHERINE L B BORDEN其他文献
KATHERINE L B BORDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHERINE L B BORDEN', 18)}}的其他基金
Molecular Mechanisms of eIF4E mediated transformation
eIF4E介导转化的分子机制
- 批准号:
10295914 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation.
eIF4E 介导转化的分子机制。
- 批准号:
7890484 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation
eIF4E介导转化的分子机制
- 批准号:
10657712 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation.
eIF4E 介导转化的分子机制。
- 批准号:
8123459 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation.
eIF4E 介导转化的分子机制。
- 批准号:
8465821 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation.
eIF4E 介导转化的分子机制。
- 批准号:
8251915 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:
Molecular Mechanisms of eIF4E mediated transformation
eIF4E介导转化的分子机制
- 批准号:
10491774 - 财政年份:2003
- 资助金额:
$ 33.94万 - 项目类别:














{{item.name}}会员




